SpyGlass Pharma, Inc. (SGP) Reports Q1 Loss of $0.69
Tweet
Share
E-mail
Get Alerts SGP Hot Sheet
Join SI Premium – FREE
SpyGlass Pharma, Inc. (NASDAQ: SGP) reported Q1 EPS of ($0.69).Revenue for the quarter came in at $0 .
For earnings history and earnings-related data on SpyGlass Pharma, Inc. (SGP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- IP Strategy Holdings receives Nasdaq noncompliance notice over late 10-Q
- Electra Therapeutics files for proposed IPO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
